probably not for at least 8 months. Will need to show steady growth for next 2 qtrs I imagine to reduce investors fear that business is starting to decline.
once we get into 2022, the PCPs will get easier and show more sustainable organic growth. Should be 15% p.a. + with good execution.
otherwise, may be a TO target from Private Equity I imagine... they like growing companies who get into trouble and they could easily see this just requires some growth capex... it's also only $500m to buy also...
balance sheet may come into focus, but expect mgt to manage costs and reduce growth capex to show better EBIT line and improve share price and investors fear.
that's what I would do. Then raise some more capital when price is back around $3 to support more growth.
So simply, they planted the seeds this year with good revenue and some debt to farm fruit next year.
the big risk here with such capacity increase is utilisation... they need to ensure demand stays to preserve margin. They are all in on that front.
- Forums
- ASX - By Stock
- MMM
- Ann: Appendix 4C - Q3 2021 and Business Activity Report
Ann: Appendix 4C - Q3 2021 and Business Activity Report, page-24
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MMM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online